 | • レポートコード：MRC2303F0166 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、250ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：産業設備 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートは、2021年に397.7億ドルであった世界のオフィスベースラボ市場規模が、2022年に430.7億ドルになり、2027年まで年平均8.45%で成長して647.4億ドルに拡大すると予測しています。本レポートでは、オフィスベースラボの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、モダリティ別（ハイブリッドラボ、マルチスペシャリティラボ、シングルスペシャリティラボ）分析、サービス別（心臓、血管内治療、インターベンショナルラジオロジー、末梢血管インターベンション、静脈）分析、スペシャリスト別（インターベンショナルカーディオスト、インターベンショナルラジオロジスト、血管外科医）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、主要企業として、Abbott Laboratories、Asklepios Kliniken GmbH & Co. KGaA、Boston Scientific Corporation、Cardiovascular Coalition、Cardiovascular System, Inc.、Eifelhöhen Klinik AG、Envision Healthcare、European Medical Center、Fresenius Medical Care、GE Healthcare、HCA Healthcare、Healthway Medical Group、Koninklijke Philips N.V.、MEDNAX Services, Inc.などの企業情報を含んでいます。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のオフィスベースラボ市場規模：モダリティ別 - ハイブリッドラボの市場規模 - マルチスペシャリティラボの市場規模 - シングルスペシャリティラボの市場規模 ・世界のオフィスベースラボ市場規模：サービス別 - 心臓の市場規模 - 血管内治療の市場規模 - インターベンショナルラジオロジーの市場規模 - 末梢血管インターベンションの市場規模 - 静脈の市場規模 ・世界のオフィスベースラボ市場規模：スペシャリスト別 - インターベンショナルカーディオストにおける市場規模 - インターベンショナルラジオロジストにおける市場規模 - 血管外科医における市場規模 ・世界のオフィスベースラボ市場規模：地域別 - 南北アメリカのオフィスベースラボ市場規模 アメリカのオフィスベースラボ市場規模 カナダのオフィスベースラボ市場規模 ブラジルのオフィスベースラボ市場規模 ... - アジア太平洋のオフィスベースラボ市場規模 日本のオフィスベースラボ市場規模 中国のオフィスベースラボ市場規模 インドのオフィスベースラボ市場規模 韓国のオフィスベースラボ市場規模 台湾のオフィスベースラボ市場規模 ... -ヨーロッパ/中東/アフリカのオフィスベースラボ市場規模 イギリスのオフィスベースラボ市場規模 ドイツのオフィスベースラボ市場規模 フランスのオフィスベースラボ市場規模 ロシアのオフィスベースラボ市場規模 ... -その他地域のオフィスベースラボ市場規模 ・競争状況 ・企業情報 |
The Global Office Based Labs Market size was estimated at USD 39.77 billion in 2021 and expected to reach USD 43.07 billion in 2022, and is projected to grow at a CAGR 8.45% to reach USD 64.74 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Office Based Labs to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Modality, the market was studied across Hybrid Labs, Multi-Specialty Labs, and Single Specialty Labs.
Based on Service, the market was studied across Cardiac, Endovascular Interventions, Interventional radiology, Peripheral Vascular Intervention, and Venous.
Based on Specialist, the market was studied across Interventional Cardiologists, Interventional Radiologists, and Vascular Surgeons.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Office Based Labs market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Office Based Labs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Office Based Labs Market, including Abbott Laboratories, Asklepios Kliniken GmbH & Co. KGaA, Boston Scientific Corporation, Cardiovascular Coalition, Cardiovascular System, Inc., Eifelhöhen Klinik AG, Envision Healthcare, European Medical Center, Fresenius Medical Care, GE Healthcare, HCA Healthcare, Healthway Medical Group, Koninklijke Philips N.V., MEDNAX Services, Inc., Medtronic PLC, National Cardiovascular Partners, LP, Quorum Health, Schön Klinik, Siemens Healthcare AG, Suomen Terveystalo Oy, Surgery Partners, Team Health, Tenet Healthcare Corporation, and UnitedHealth Group.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Office Based Labs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Office Based Labs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Office Based Labs Market?
4. What is the competitive strategic window for opportunities in the Global Office Based Labs Market?
5. What are the technology trends and regulatory frameworks in the Global Office Based Labs Market?
6. What is the market share of the leading vendors in the Global Office Based Labs Market?
7. What modes and strategic moves are considered suitable for entering the Global Office Based Labs Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased R&D investments in pharmaceutical industries
5.1.1.2. Increasing prevalence of target diseases and vascular diseases
5.1.1.3. Growth and preference for minimally invasive procedures
5.1.2. Restraints
5.1.2.1. Complications arising from high-end cases
5.1.3. Opportunities
5.1.3.1. Rising demand for outpatient procedures for patient convenience and safety
5.1.3.2. Evolution of collaborative growth for launching new office-based labs
5.1.4. Challenges
5.1.4.1. Scarce of skill sets of physicians and surgeons
5.2. Cumulative Impact of COVID-19
6. Office Based Labs Market, by Modality
6.1. Introduction
6.2. Hybrid Labs
6.3. Multi-Specialty Labs
6.4. Single Specialty Labs
7. Office Based Labs Market, by Service
7.1. Introduction
7.2. Cardiac
7.3. Endovascular Interventions
7.4. Interventional radiology
7.5. Peripheral Vascular Intervention
7.6. Venous
8. Office Based Labs Market, by Specialist
8.1. Introduction
8.2. Interventional Cardiologists
8.3. Interventional Radiologists
8.4. Vascular Surgeons
9. Americas Office Based Labs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Office Based Labs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Office Based Labs Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Asklepios Kliniken GmbH & Co. KGaA
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Boston Scientific Corporation
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Cardiovascular Coalition
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Cardiovascular System, Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Eifelhöhen Klinik AG
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Envision Healthcare
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. European Medical Center
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Fresenius Medical Care
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. GE Healthcare
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. HCA Healthcare
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Healthway Medical Group
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Koninklijke Philips N.V.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. MEDNAX Services, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Medtronic PLC
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. National Cardiovascular Partners, LP
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Quorum Health
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Schön Klinik
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Siemens Healthcare AG
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Suomen Terveystalo Oy
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Surgery Partners
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Team Health
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Tenet Healthcare Corporation
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. UnitedHealth Group
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing